News Sort by Year All Years 2023 (8) 2022 (31) 2021 (33) 2020 (37) 2019 (7) 2018 (4) Search May 23, 2023 TFF Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference May 11, 2023 TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results May 4, 2023 TFF Pharmaceuticals Enters into CRADA with the National Institute of Environmental Health Sciences to Develop Dry Powder Formulations of Hyaluronan to Prevent and Treat Respiratory Diseases May 1, 2023 TFF Pharmaceuticals Receives Additional Funding from Leidos to Advance Next-Generation Personalized Protective Biosystems under the DARPA PPB Program March 7, 2023 TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results March 6, 2023 TFF Pharmaceuticals to Participate in the 35th Annual Roth Conference February 8, 2023 TFF Pharmaceuticals Appoints Harlan Weisman, M.D. as Permanent Chief Executive Officer January 9, 2023 TFF Pharmaceuticals Announces the Appointment of Zamaneh Mikhak, M.D. as Chief Medical Officer December 5, 2022 TFF Pharmaceuticals Announces Leadership Transition November 29, 2022 TFF Pharmaceuticals Announces Closing of $12.3 Million Public Offering